Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ablate and Pace: Is There Still a Role?

Alexandru B Chicos1, Bradley P Knight

  • 1Division of Cardiology, Department of Internal Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Cardiac Electrophysiology Clinics
|March 5, 2016
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Two Pulsed Field Ablation Systems for Atrial Fibrillation: One-Year Outcomes From a Multicenter Registry.

Journal of cardiovascular electrophysiology·2026
Same author

Multicenter analysis of device-detected atrial fibrillation burden reduction after antiarrhythmic drug initiation.

Heart rhythm O2·2026
Same author

Performance and Safety of the Extravascular Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy.

JACC. Clinical electrophysiology·2026
Same author

Reablation of atrial fibrillation targeting electrogram dispersion in patients with isolated veins: The RESTART trial.

Heart rhythm·2026
Same author

Postoperative Atrial Arrhythmias After Lung Transplantation: A Single Center Analysis of Risk Factors, Management, and Outcomes.

Clinical transplantation·2026
Same author

"Response by Kalluri et al. to Letter Regarding Article," "Catheter Ablation: Evolution and Efficiencies".

Journal of cardiovascular electrophysiology·2026
Same journal

Sweating the Details: A Reflective Pause in our Procedural Workflow.

Cardiac electrophysiology clinics·2026
Same journal

Patent Foramen Ovale and Atrial Septal Defect.

Cardiac electrophysiology clinics·2026
Same journal

Patent Foramen Ovale Embryology, Anatomy, and Physiology.

Cardiac electrophysiology clinics·2026
Same journal

Management of Arrhythmias in the Cardiovascular Intensive Care Unit.

Cardiac electrophysiology clinics·2026
Same journal

Left Ventricular Assist Device Emergencies: Diagnosis and Management.

Cardiac electrophysiology clinics·2026
Same journal

Advanced Critical Care Techniques in the Field.

Cardiac electrophysiology clinics·2026
See all related articles

Ablation of the atrioventricular junction (AVJ) remains a valuable treatment for atrial fibrillation (AF) patients unresponsive to medication. This "ablate and pace" strategy improves quality of life and cardiac function.

Area of Science:

  • Cardiology
  • Electrophysiology

Background:

  • Atrial fibrillation (AF) management often involves rhythm control strategies.
  • Medical therapy and newer procedures may not be effective for all AF patients.
  • Refractory AF can lead to reduced quality of life and ventricular dysfunction.

Purpose of the Study:

  • To review the
  • ablate and pace
  • strategy for managing AF.
  • To discuss patient selection, techniques, outcomes, and applications of AV junction ablation.
  • To highlight the need for further research, including randomized clinical trials.

Main Methods:

  • Comprehensive literature review on AV junction ablation for AF.
  • Analysis of historical context, current techniques, and patient outcomes.

Related Experiment Videos

  • Identification of knowledge gaps and future research directions.

    • Main Results:

    • AV junction ablation is a viable option for selected AF patients refractory to medical therapy.
    • The
    • ablate and pace
    • strategy can improve quality of life.
    • This approach can prevent ventricular dysfunction and optimize cardiac resynchronization therapy.

    Conclusions:

    • AV junction ablation remains an important therapeutic option for specific AF patient populations.
    • Further randomized clinical trials are needed to fully elucidate the benefits and optimal application of this strategy in diverse patient groups.